<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240302061141N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-05-28</date_registration>
      <primary_sponsor>Shahre-kord University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the outcome of two methods of pilonidal sinus surgery, tie-over and simple repair</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the outcome of two methods of pilonidal sinus surgery, tie-over and simple repair during 2023-2024 in patients admitted to Shahrekord Ayatollah Kashani Hospital.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-03-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>220</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/75798</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Blinding description: Patients are randomly and equally divided into two groups A (tie-over surgery) and B (simple repair surgery) (each patient goes to group A and B alternately After filing the hospital admission file, so that the first patient After the start of the study placed in group A and the next patient is placed in group B, and so on until the last patient.
Due to the fact that the patients must be informed about the type of operation and due to the fact that the researcher will perform the surgery himself, blinding is not possible at this stage, but after collecting the samples and providing the information to the analyst, blinding will be done and analysis is done based on the first and second groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Pilonidal sinus.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group: In the simple repair method, the pilonidal sinus is completely removed. After the hole is completely washed, a No. 14 hemovac drain will be inserted into the incision and exit from the upper part of the incision, and a cover will be used to suck blood from the wound. Then 0-2 Vicryl will be used to press the subcutaneous tissue together and the skin will be repaired using 0-3 nylon. Intervention 2: The second intervention group: First, an elliptical incision will be made on their skin and the sinus will be completely removed up to the perisacral fascia. Then, using a cover, the subcutaneous tissue and skin will be removed from the medius and two flaps will be created on both sides of the wound. After completely washing the hole and removing the blood using the cover, and if there is no bleeding, the skin and subcutaneous tissue and the entire presacral fascia will be sutured using 3 tension stitches using nylon 0-1, the cut in the upper and middle part will be sutured. . After this step, the freed flaps will be sutured together using absorbable suture (0-2 Vicryl). Then the subcutaneous tissue is brought together. In the last step, the layers of the skin are brought together using 0-3 nylon with round and close sutures so that the edges of the wound are overlapped.Then a bandage will be placed on the wound and it will be closed using tension stitches.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Questionnaire form and informed consent as well as clinical examination results that have been recorded

When:
6 months after the results are published

To whom:
The data is accessible to researchers working in academic institutions

Conditions:
The use of the delivered data is allowed only for a more detailed examination and to help choose the preferred method of pilonidal sinus surgery.
Statistical analysis to help further research is allowed

Where to obtain:
Dr Behrooz Behzadi
Email : behbehzadi@yahoo.com
mobile : 09137293913

How to obtain:
After contacting via e-mail or phone call or text message, after identifying the requester and ensuring that the data is not misused, the file containing the data will be sent to them.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Behrooz Behzadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 25, 26 Alley., Varzesh Ave., Shahrekord Town,</address>
        <city>Shahr-e-kord</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8815854476</zip>
        <telephone>+98 35 3623 7273</telephone>
        <email>behbehzadi@yahoo.com</email>
        <affiliation>Shahre-kord University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Behrooz Behzadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 25, 26 Alley., Varzesh Ave., Shahrekord Town,</address>
        <city>Shahr-e-kord</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8815854476</zip>
        <telephone>+98 35 3623 7273</telephone>
        <email>behbehzadi@yahoo.com</email>
        <affiliation>Shahre-kord University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All male and female patients diagnosed with sacral pilonidal sinus
The age of patients entering the study is 15 to 50 years
Patients who have completed the consent form</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with diabetes
Patients with weak immune system
Patients with cancer
Patients with collagen vascular disease</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>L05</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Pilonidal cyst and sinus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group: In the simple repair method, the pilonidal sinus is completely removed. After the hole is completely washed, a No. 14 hemovac drain will be inserted into the incision and exit from the upper part of the incision, and a cover will be used to suck blood from the wound. Then 0-2 Vicryl will be used to press the subcutaneous tissue together and the skin will be repaired using 0-3 nylon.</i_keyword>
      <i_keyword>The second intervention group: First, an elliptical incision will be made on their skin and the sinus will be completely removed up to the perisacral fascia. Then, using a cover, the subcutaneous tissue and skin will be removed from the medius and two flaps will be created on both sides of the wound. After completely washing the hole and removing the blood using the cover, and if there is no bleeding, the skin and subcutaneous tissue and the entire presacral fascia will be sutured using 3 tension stitches using nylon 0-1, the cut in the upper and middle part will be sutured. . After this step, the freed flaps will be sutured together using absorbable suture (0-2 Vicryl). Then the subcutaneous tissue is brought together. In the last step, the layers of the skin are brought together using 0-3 nylon with round and close sutures so that the edges of the wound are overlapped.Then a bandage will be placed on the wound and it will be closed using tension stitches.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Age of people by year. Timepoint: Knowing the patient's age when admitted to the hospital. Method of measurement: Hospital admission file.</prim_outcome>
      <prim_outcome>Gender of the patient. Timepoint: Knowing the patient's gender when admitted to the hospital. Method of measurement: Hospital admission file.</prim_outcome>
      <prim_outcome>Patient's job. Timepoint: Information about the patient's occupation at the beginning of the study. Method of measurement: through a questionnaire.</prim_outcome>
      <prim_outcome>Marital status of the patient. Timepoint: At the beginning of the study when the patient was admitted. Method of measurement: Hospital admission file.</prim_outcome>
      <prim_outcome>The amount of pain after surgery. Timepoint: Day 1 and day 6 after surgery. Method of measurement: through a questionnaire.</prim_outcome>
      <prim_outcome>Postoperative wound infection. Timepoint: 6th day and 6 months after surgery. Method of measurement: Clinical examination of the patient.</prim_outcome>
      <prim_outcome>Recurrence of the disease. Timepoint: 6 months after the operation. Method of measurement: Clinical examination of the patient.</prim_outcome>
      <prim_outcome>Bleeding from the operation site. Timepoint: 1 and 6 days after surgery. Method of measurement: Clinical examination of the patient.</prim_outcome>
      <prim_outcome>Postoperative satisfaction rate. Timepoint: 6 days and 6 months after surgery. Method of measurement: through a questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahre-kord University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-04-06</approval_date>
        <contact_name>Ethics Committee of Shahrekord University of Medical Sciences</contact_name>
        <contact_address>No. 25, 26 Alley, Varzesh Ave. Shahr-e-kord Chahar-Mahal-va-Bakhtiari Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
